300584.SZ
海辰药业
SZSE · Healthcare · C 制造业 · CN
CNY 32.79
−0.33%Margins
Gross margin
80.8%
EBITDA margin
16.0%
EBIT margin
6.5%
Net margin
6.4%
FCF margin
-0.4%
4.1%
Return on equity
2.9%
Return on assets
3.4%
Return on invested capital
0.45x
Asset turnover
CNY 45.5M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026